| # | Drug | Count |
|---|---|---|
| 0 | VENETOCLAX | 36 |
| 1 | DEXAMETHASONE | 17 |
| 2 | DEXAMETHASONE 1.5 MG | 17 |
| 3 | BORTEZOMIB | 16 |
| 4 | CYCLOPHOSPHAMIDE | 14 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 14 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 14 |
| 7 | LENALIDOMIDE | 14 |
| 8 | MELPHALAN HYDROCHLORIDE | 13 |
| 9 | MORPHINE SULFATE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEFEROXAMINE MESYLATE | 4 | 0.0018 |
| 1 | CROTAMITON | 1 | 0.0016 |
| 2 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 3 | TOLNAFTATE | 1 | 0.0008 |
| 4 | PSYLLIUM HUSK | 1 | 0.0007 |
| 5 | VENETOCLAX | 36 | 0.0006 |
| 6 | MELPHALAN HYDROCHLORIDE | 13 | 0.0005 |
| 7 | RYDAPT | 1 | 0.0005 |
| 8 | MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN | 1 | 0.0005 |
| 9 | ZINC OXIDE OINTMENT | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 36 |
| 1 | Corticosteroid [EPC] | 25 |
| 2 | Azole Antifungal [EPC] | 19 |
| 3 | Proteasome Inhibitor [EPC] | 16 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 15 |
| 5 | Alkylating Drug [EPC] | 14 |
| 6 | Thalidomide Analog [EPC] | 14 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 8 | Loop Diuretic [EPC] | 9 |
| 9 | Complement Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 36 | 0.0006 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 3 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 4 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 5 | Proteasome Inhibitor [EPC] | 16 | 0.0001 |
| 6 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Complement Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 9 | Azole Antifungal [EPC] | 19 | 0.0001 |